Observational Study
Copyright ©The Author(s) 2021.
World J Gastrointest Surg. Nov 27, 2021; 13(11): 1463-1483
Published online Nov 27, 2021. doi: 10.4240/wjgs.v13.i11.1463
Table 1 Sample characteristics, n (%)
Characteristic
n (%)
Year of diagnosis
2004-20063142 (27)
2007-20093028 (26)
2010-20122850 (25)
2013-20152587 (22)
Age at diagnosis (yr)
Median (range)69 (12-99)
Sex
Male6697 (58)
Female4910 (42)
Race
White7045 (61)
Black2076 (18)
Asian/Pacific2486 (21)
Marital status
Single/divorced2539 (22)
Married6805 (58)
Widowed1837 (16)
NA426 (4)
Insurance status
Insured8033 (69)
Uninsured432 (4)
NA3142 (27)
Site of tumor
Fundus/body1866 (16)
Antrum/pylorus4626 (40)
Overlapping lesion1299 (11)
Stomach, NOS3816 (33)
Tumor size (cm)
≤ 55431 (47)
5.1-104203 (36)
≥ 10.11135 (10)
NA838 (7)
Histology
ADC, NOS4481 (39)
Signet ring cell carcinoma2726 (23)
ADC, instestinal type1943 (17)
Carcinoma, diffuse type958 (8)
ADC with mixed subtypes424 (4)
Other1075 (9)
Grade
Well/moderately differentiated2674 (23)
Poorly/undifferentiated8524 (73)
NA409 (4)
T stage, 8th ed.
T1290 (2)
T2943 (8)
T35569 (48)
T4a3551 (31)
T4b1254 (11)
N stage, 8th ed.
N02863 (25)
N12422 (21)
N22757 (24)
N3a2498 (21)
N3b1067 (9)
Stage, 8th ed.
IIA2585 (22)
IIB2129 (18)
IIIA3049 (26)
IIIB2511 (22)
IIIC1333 (12)
Chemotherapy
Yes6473 (56)
No5134 (44)
Neoadjuvant chemotherapy
Yes1255 (11)
No10352 (89)
Radiotherapy
Yes4285 (37)
No7322 (63)
Type of surgery
Partial gastrectomy8320 (72)
Total gastrectomy3287 (28)
Number of retrieved lymphnodes
< 16 LNs (ILA)5806 (50)
16-29 LNs (ALA)4085 (35)
≥ 30 LNs (OLA)1716 (15)